Biologic Tx to distribute Envarsus
"BiologicTx's primary focus and responsibility is to provide the transplant patient with the best possible products to help maintain their health and longevity of their transplanted organ," Sal Rafanelli, RPh, CEO and co-founder of BiologicTx, said. "The ability to offer a product like Envarsus® XR allows us continue to provide the best possible medications to our patient population."
As a pharmacy that focuses on specialty areas, particularly transplants, Biologic Tx is looking forward to having the drug. Envarsus helps transplant recipients suppress kidney rejections.